Intravenous patient-controlled analgesia with esketamine improves early depressive symptoms in patients with postherpetic neuralgia: a single-center retrospective cohort study
Abstract Objective Patients with Postherpetic Neuralgia (PHN) often exhibit depressive-like symptoms, significantly impacting their quality of life. Esketamine, known for its analgesic properties, has also been recognized for its rapid antidepressant effects. However, its efficacy in the treatment o...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMC
2024-08-01
|
| Серии: | BMC Psychiatry |
| Предметы: | |
| Online-ссылка: | https://doi.org/10.1186/s12888-024-06035-0 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|